BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 1672481)

  • 21. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
    Frick MH; Luurila O
    Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Celiprolol in the treatment of chronic stable angina].
    Román O; Cuevas G; Martínez D; Vargas W
    Rev Med Chil; 1991 Jan; 119(1):50-5. PubMed ID: 1688095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR; Mir MA
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
    Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E
    Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol and propranolol for unstable angina pectoris.
    Cleophas TJ; van 't Leven M; Kauw FH; Remmert HP; Kuijper A; Zwinderman K
    Clin Pharmacol Ther; 1995 Jan; 57(1):67-72. PubMed ID: 7828384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG; Shanks RG; Brogden RN
    Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ; Buckley MM
    Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
    Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
    Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative study of celiprolol and nicardipine in stable angina of effort].
    Prohías Martínez JA; Chaple M; Rivero-Varona MM; Hernández-Acosta K; Toruncha-Chukram A; García-Barreto D
    Arch Inst Cardiol Mex; 1991; 61(4):345-9. PubMed ID: 1683217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.